Kashef Mohammad Amin, Friderici Jennifer, Hernandez-Montfort Jaime, Atreya Auras R, Lindenauer Peter, Lagu Tara
Division of Cardiovascular Disease, Baystate Medical Center, Springfield, Massachusetts; Tufts University School of Medicine, Department of Medicine, Boston, Massachusetts.
Tufts University School of Medicine, Department of Medicine, Boston, Massachusetts; Division of Academic Affairs, Baystate Medical Center, Springfield, Massachusetts.
J Hosp Med. 2017 Jun;12(6):414-420. doi: 10.12788/jhm.2746.
There have been no recent studies describing the management and outcomes of patients with infective endocarditis (IE).
We conducted a retrospective cohort study of adult patients admitted to a tertiary medical center from 2007 to 2011 with a Duke criteria consistent discharge diagnosis of IE. We examined concordance with guideline recommendations. Outcomes included embolic events, inhospital and 1-year mortality, length of stay (LOS) and cardiac surgery. We used descriptive statistics to describe the cohort and Fisher exact and unpaired t tests to compare native valve endocarditis (NVE) with prosthetic valve endocarditis (PVE).
Of 170 patients, definite IE was present in 135 (79.4%) and possible IE in 35 (20.6%); 74.7% had NVE, and 25.3% had PVE. Mean ± standard deviation age was 60.0 ± 17.9 years. Comparing PVE to NVE, patients with PVE were less likely to have embolic events (14.0% vs. 32.3%; P = 0.03), had shorter LOS (median 12.0 days vs. 14.0 days; P = 0.047), but they did not show a statistically significant difference in inhospital mortality (20.9% vs. 12.6%; P = 0.21). Of 170, patients 27.6% (n = 47) underwent valve surgery. Most patients received timely blood cultures and antibiotics. Guideline-recommended consults were underused, with 86.5%, 54.1%, and 47.1% of patients receiving infectious disease, cardiac surgery, and cardiology consultation, respectively. As the number of consultations increased (from 0 to 3), we observed a nonsignificant trend toward reduction in 6-month readmission and 12-month mortality.
IE remains a disease with significant morbidity and mortality. There are gaps in the care of IE patients, most notably underuse of specialty consultation. Journal of Hospital Medicine 2017;12:414-420.
近期尚无关于感染性心内膜炎(IE)患者管理及预后的研究。
我们对2007年至2011年入住一家三级医疗中心、出院诊断符合杜克标准的成年IE患者进行了一项回顾性队列研究。我们检查了与指南建议的一致性。结局包括栓塞事件、住院期间及1年死亡率、住院时间(LOS)和心脏手术。我们使用描述性统计来描述该队列,并使用Fisher精确检验和非配对t检验来比较自体瓣膜心内膜炎(NVE)和人工瓣膜心内膜炎(PVE)。
170例患者中,确诊IE的有135例(79.4%),可能IE的有35例(20.6%);74.7%为NVE,25.3%为PVE。平均年龄±标准差为60.0±17.9岁。与NVE相比,PVE患者发生栓塞事件的可能性较小(14.0%对32.3%;P = 0.03),住院时间较短(中位数12.0天对14.0天;P = 0.047),但住院死亡率无统计学显著差异(20.9%对12.6%;P = 0.21)。170例患者中,27.6%(n = 47)接受了瓣膜手术。大多数患者及时进行了血培养并使用了抗生素。指南推荐的会诊未得到充分利用,分别有86.5%、54.1%和47.1%的患者接受了感染病科、心脏外科和心内科会诊。随着会诊次数增加(从0次到3次),我们观察到6个月再入院率和12个月死亡率有下降趋势,但无统计学意义。
IE仍然是一种具有显著发病率和死亡率的疾病。IE患者的护理存在差距,最明显的是专科会诊利用不足。《医院医学杂志》2017年;12:414 - 420。